Publications by authors named "Sven Reske"

Claim this Profile
D
Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and C-methionine positron emission tomography in resection of glioblastoma: a prospective study.
Andrej Pala, Sven N Reske, Nina Eberhardt, Angelika Scheuerle, Ralph König

Neurosurg Rev· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Laura Evangelista, Alberto Briganti, Stefano Fanti, Stephen Joniau, Sven Reske

Eur Urol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically Based Pharmacokinetic Modeling Is Essential in 90Y-Labeled Anti-CD66 Radioimmunotherapy.
Peter Kletting, Christian Maaß, Sven Reske, Ambros J Beer, Gerhard Glatting

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro.
Noeen Malik, Benjamin Baur, Gordon Winter, Sven N Reske, Ambros J Beer

Mol Imaging Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography.
Cordula A Jilg, Wolfgang Schultze-Seemann, Vanessa Drendel, Werner Vach, Gesche Wieser, Sven N Reske

J Urol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
Larissa Miller, Gordon Winter, Benjamin Baur, Barbara Witulla, Christoph Solbach, Sven Reske

Nanoscale· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep.
Benjamin Baur, Christoph Solbach, Elena Andreolli, Gordon Winter, Hans-Jürgen Machulla, Sven N Reske

Pharmaceuticals (Basel)· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Annette Pflugfelder, Corinna Kochs, Andreas Blum, Marcus Capellaro, Christina Czeschik, Sven Reske

J Dtsch Dermatol Ges· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.
Theresia Weber, Clemens Maier-Funk, Dagmar Ohlhauser, Andreas Hillenbrand, Gregor Cammerer, Sven N Reske

Ann Surg· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Sven Norbert Reske, Gordon Winter, Benjamin Baur, Hans-Jürgen Machulla, Thomas Kull

Eur J Nucl Med Mol Imaging· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version.
Annette Pflugfelder, Corinna Kochs, Andreas Blum, Marcus Capellaro, Christina Czeschik, Sven Reske

J Dtsch Dermatol Ges· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief S2k guidelines--Merkel cell carcinoma.
Jürgen C Becker, Chalid Assaf, Dirk Vordermark, Sven N Reske, Jörg Hense

J Dtsch Dermatol Ges· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
Ansje S Fortuin, Willem M L L G Deserno, Hanneke J M Meijer, Gerrit J Jager, Satoru Takahashi, Sven N Reske

Int J Radiat Oncol Biol Phys· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy.
Peter Kletting, Berthold Muller, Bahar Erentok, Jorn Schmaljohann, Florian F Behrendt, Sven N Reske

Med Phys· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Sandra Pauls, Stefan A Schmidt, Markus S Juchems, Oliver Klass, Markus Luster, Sven Norbert Reske

Eur J Radiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation study.
Peter Kletting, Sven N Reske, Gerhard Glatting

Z Med Phys· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[For the benefit of the patient: the sentinel node excision].
Imke Satzger, Martin Klein, Christoph Löser, Matthias Möhrle, Sven Reske

J Dtsch Dermatol Ges· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridine.
Agnieszka Morgenroth, Cornelia Dinger, Boris D Zlatopolskiy, Ehab Al-Momani, Gerhard Glatting, Sven N Reske

Nucl Med Biol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors.
Agnieszka Morgenroth, Elizaveta A Urusova, Cornelia Dinger, Ehab Al-Momani, Thomas Kull, Sven N Reske

Chemistry· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep).
Noeen Malik, Hans-Jürgen Machulla, Christoph Solbach, Gordon Winter, Sven N Reske

Appl Radiat Isot· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal preloading in radioimmunotherapy with anti-cD45 antibody.
Peter Kletting, Thomas Kull, Donald Bunjes, M Luster, Sven N Reske

Med Phys· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.
Ansgar S Schulz, Gerhard Glatting, Manfred Hoenig, Catharina Schuetz, Susanne A Gatz, Sven N Reske

Blood· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
Maria Picchio, Alberto Briganti, Stefano Fanti, Axel Heidenreich, Bernd J Krause, Sven N Reske

Eur Urol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysing saturable antibody binding based on serum data and pharmacokinetic modelling.
Peter Kletting, Hady Kiryakos, Sven N Reske, Gerhard Glatting

Phys Med Biol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
Jonas Schreyögg, Julia Weller, Tom Stargardt, Ken Herrmann, Christina Bluemel, Sven N Reske

J Nucl Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis